VitaPCR™ Assays Enable Detection of Influenza Virus New Variants
Singapore – Detection of Influenza virus variants In response to the emergence of Influenza virus variants, and to mitigate any potential risks these may present to our assay performance, Credo Diagnostics conducted the BLASTn analysis (with the oligonucleotide primers and probes of the assays involving Influenza A virus detection) against the sequences of circulating Influenza […]
VitaPCR™ SARS-CoV-2 Gen 2 Assay receives approval for continued distribution in the United Kingdom
On 28 October 2022, Credo Diagnostics Biomedical received confirmation from the UK Health Security Agency that the VitaPCR™ SARS-CoV-2 Gen 2 Assay has been approved under the requirements set out in The Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations 2021. VitaPCR™ SARS-CoV-2 Gen 2 Assay is a rapid molecular in-vitro diagnostic solution, using real-time […]
Detection of Influenza A H3N2 virus
In response to the emergence of variants of influenza A H3N2 viruses, and to mitigate any potential risks that these variants may have on our assay performance, we, Credo Diagnostics Biomedical, have performed the BLASTn analysis (with the oligonucleotide primers and probes of the assays involving Influenza A virus detection) against the sequences of eight […]
Credo Diagnostics’ booth at AACC 2022 has officially opened
At the 2019 AACC in Anaheim, CA, Booth #4339, Credo Diagnostics launched our VitaPCR™ Instrument and our first VitaPCR™ Influenza A&B Assay. After one year, our product lines include the VitaPCR™ SARS-CoV-2 Gen 2 Assay, VitaPCR™ Influenza/SARS-CoV-2 Assay, VitaPCR™ Influenza/RSV Assay, and VitaPCR™ Strep A Assay. For AACC 2022 in Chicago, Credo Diagnostics are happy […]
Credo Diagnostics will be present at the AACC event in Chicago, USA.
Credo Diagnostics is pleased to announce our participation at the coming 2022 AACC Annual Scientific Meeting & Clinical Lab Expo event from July 26 – 28, 2022 in Chicago, IL, USA. The AACC Annual Scientific Meeting & Clinical Lab Expo is the world’s leading global professional gathering for clinical chemistry, molecular diagnostics, mass spectrometry, translational […]
VitaPCR™ SARS-CoV-2 RNA detection Assay can correctly detect Omicron sub-lineages BA.4 and BA.5
In response to the new Omicron variant (also known as B.1.1.529), we, Credo Diagnostics Biomedical Pte Ltd, have performed the BLASTn analysis (with the oligonucleotide primers and probes of the assays involving SARS-CoV-2 detection) against the sequences listed in GISAID on May 25th, 2022. According to our analysis, we confirm that our SARS-CoV-2 RNA detection […]
Credo Diagnostics’ booth at 32nd ECCMID 2022 has officially opened
Taiwan, April 23, 2022 – Credo Diagnostics presents at 32nd ECCMID, Lisbon, Portugal, on April 23 – 26, 2022. ECCMID is recognized as the world’s premier Clinical Microbiology & Infectious Diseases event and brings together experts from many fields to present their latest findings, guidelines, and experiences to an audience of 14,000 visitors. This year, […]
Credo Diagnostics will be present at the 32nd ECCMID event in Lisbon, Portugal
Credo Diagnostics is pleased to announce our participation at the coming 32nd ECCMID event from April 23 – 26, 2022. ECCMID is recognized as the world’s premier Clinical Microbiology & Infectious Diseases event and brings together experts from many fields to present their latest findings, guidelines, and experiences to an audience of 14,000 visitors. This […]
Credo Diagnostics Biomedical celebrates its 11th anniversary and moves Singapore headquarters into a new office
Credo Diagnostics Biomedical Pte Ltd is pleased to announce the celebration of its 11th anniversary and official move into a new office at #06-01 Valley Point, Singapore. “Since our incorporation on 22nd March 2011, we have grown and weathered many storms. COVID-19 was a game-changing moment as we were given a chance to participate in […]
Credo Diagnostics’ booth at Medical Japan Osaka 2022 has officially opened
Taiwan, February 24, 2022 – Credo Diagnostics presents at Medical Japan Osaka on February 24 – 26, 2022. Medical Japan is Japan’s leading trade show consisting of specialized shows for the Medical, Elderly Care, and Pharmacy industries. This exhibition consists of 5 shows, including hospital exposition, clinics exposition, pharmacy solutions exposition, elderly care & nursing […]
